← Leaderboards
Daniel Patrick Kelly
University Of Pennsylvania
$33,087,106
Attributed
$41,276,146
Total exposure
27
Grants
17
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.6M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$61,710,685 · 30
By mechanism
R01$30,339,654 · 5
P50$21,714,927 · 5
P20$3,494,500 · 11
T32$2,814,875 · 1
R35$1,137,498 · 1
P01$1,088,789 · 1
Top collaborators
- Deborah M Muoio12 shared
- Thomas P Cappola4 shared
- Fabio A Recchia4 shared
- Tod Gulick2 shared
- Gregory Paul Roth2 shared
- Rolf Bodmer1 shared
- Sharlene M Day1 shared
- Rajan Jain1 shared
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Rajat Deo$2,978,625
- Philip Richard Gehrman$7,084,520
- Wei Yang$1,107,340
- Garret A Fitzgerald$242,218,424
- Richard Assoian$21,573,073
Others in their field
Top investigators on “Mitochondria”
- Bruce M Spiegelman · Dana-Farber Cancer Inst$30,163,696
- Shi Du Yan · Columbia University Health Sciences$29,685,201
- Peipei Ping · University Of California Los Angeles$27,344,561
- Mary McGrae McDermott · Northwestern University$25,752,019
- Vamsi Krishna Mootha · Massachusetts General Hospital$23,004,991
- Kenneth D. Tew · Fox Chase Cancer Center$22,000,362
Research focus
MitochondriaMetabolicHeart FailurePathway InteractionsHeartChronicFatty AcidsFundingCardiac MyocytesCardiacPhenotypeDesignGlucosePathologicFatty Acid OxidationSignal TransductionMetabolismGenesEventPeroxisome Proliferator-Activated ReceptorsMolecularBaseMetabolomicsTranscription Factor
Grant awards (113)
Locking and Unlocking Cardiac Maturation$1,137,498
R35 · FY2025 · HL · contact PI
Training Program in Cardiovascular Biology and Medicine$770,155
T32 · FY2025 · HL
Probing the Cardiac PGC-1 Regulatory Cascade$639,721
R01 · FY2024 · HL · contact PI
Training Program in Cardiovascular Biology and Medicine$587,441
T32 · FY2024 · HL
Targeting Ketone Metabolism as a Novel Heart Failure Therapy$802,632
R01 · FY2023 · HL · contact PI
Training Program in Cardiovascular Biology and Medicine$743,264
T32 · FY2023 · HL
Probing the Role of Mitochondrial Short-chain Carbon Homeostasis in the Hypertrophied and Failing Heart$719,480
R01 · FY2023 · HL · contact PI
Probing the Cardiac PGC-1 Regulatory Cascade$650,346
R01 · FY2023 · HL · contact PI
Metabolomics Shared Resource$1
P30 · FY2023 · CA · contact PI
Targeting Ketone Metabolism as a Novel Heart Failure Therapy$802,632
R01 · FY2022 · HL · contact PI
Probing the Role of Mitochondrial Short-chain Carbon Homeostasis in the Hypertrophied and Failing Heart$723,674
R01 · FY2022 · HL · contact PI
Training Program in Cardiovascular Biology and Medicine$714,015
T32 · FY2022 · HL
Probing the Cardiac PGC-1 Regulatory Cascade$653,559
R01 · FY2022 · HL · contact PI
Metabolomics Shared Resource$2,136
P30 · FY2022 · CA · contact PI
Targeting Ketone Metabolism as a Novel Heart Failure Therapy$802,315
R01 · FY2021 · HL · contact PI
Probing the Role of Mitochondrial Short-chain Carbon Homeostasis in the Hypertrophied and Failing Heart$743,357
R01 · FY2021 · HL · contact PI
Probing the Cardiac PGC-1 Regulatory Cascade$649,914
R01 · FY2021 · HL · contact PI
Metabolomics Shared Resource$2
P30 · FY2021 · CA · contact PI
Targeting Ketone Metabolism as a Novel Heart Failure Therapy$816,865
R01 · FY2020 · HL · contact PI
Molecular Control of Muscle Fuel Metabolism$430,269
R01 · FY2020 · DK · contact PI
Probing the Role of Mitochondrial Short-chain Carbon Homeostasis in the Hypertrophied and Failing Heart$713,632
R01 · FY2019 · HL · contact PI
Molecular Control of Muscle Fuel Metabolism$427,627
R01 · FY2019 · DK · contact PI
Probing the Role of Mitochondrial Short-chain Carbon Homeostasis in the Hypertrophied and Failing Heart$722,090
R01 · FY2018 · HL · contact PI
Probing the Cardiac PGC-1 Regulatory Cascade$531,746
R01 · FY2018 · HL · contact PI
Molecular Control of Muscle Fuel Metabolism$434,238
R01 · FY2018 · DK · contact PI
Probing the Role of Mitochondrial Short-chain Carbon Homeostasis in the Hypertrophied and Failing Heart$622,524
R01 · FY2017 · HL · contact PI
Probing the Cardiac PGC-1 Regulatory Cascade$500,470
R01 · FY2017 · HL · contact PI
Molecular Control of Muscle Fuel Metabolism$452,998
R01 · FY2017 · DK · contact PI
Probing the Role of Mitochondrial Short-chain Carbon Homeostasis in the Hypertrophied and Failing Heart$247,089
R01 · FY2017 · HL · contact PI
Probing the Cardiac PGC-1 Regulatory Cascade$178,490
R01 · FY2017 · HL · contact PI
Probing the Role of Mitochondrial Short-chain Carbon Homeostasis in the Hypertrophied and Failing Heart$925,193
R01 · FY2016 · HL · contact PI
Probing the Cardiac PGC-1 Regulatory Cascade$487,500
R01 · FY2016 · HL · contact PI
Molecular Control of Muscle Fuel Metabolism$607,333
R01 · FY2015 · DK · contact PI
Probing the Cardiac PGC-1 Regulatory Cascade$487,500
R01 · FY2015 · HL · contact PI
Molecular Control of Muscle Fuel Metabolism$607,333
R01 · FY2014 · DK · contact PI
Probing the Cardiac PGC-1 Regulatory Cascade$472,972
R01 · FY2014 · HL · contact PI
A Genomic/Metabolomic Strategy to Characterize Cardiac Mitochondrial Dysfunction$691,570
R01 · FY2013 · HL · contact PI
Molecular Control of Muscle Fuel Metabolism$586,076
R01 · FY2013 · DK · contact PI
Probing the Cardiac PGC-1 Regulatory Cascade$459,459
R01 · FY2013 · HL · contact PI
Probing the Cardiac PGC-1 Regulatory Cascade$37,128
R01 · FY2013 · HL · contact PI
A Genomic/Metabolomic Strategy to Characterize Cardiac Mitochondrial Dysfunction$727,018
R01 · FY2012 · HL · contact PI
Molecular Control of Muscle Fuel Metabolism$576,650
R01 · FY2012 · DK · contact PI
Probing the Cardiac PGC-1 Regulatory Cascade$472,725
R01 · FY2012 · HL · contact PI
Probing the Cardiac PGC-1 Regulatory Cascade$39,000
R01 · FY2012 · HL · contact PI
A Genomic/Metabolomic Strategy to Characterize Cardiac Mitochondrial Dysfunction$727,580
R01 · FY2011 · HL · contact PI
Molecular Control of Muscle Fuel Metabolism$536,011
R01 · FY2011 · DK · contact PI
An interdisciplinary approach to elucidate mechanisms of muscle lipotoxicity$500,000
R24 · FY2011 · DK · contact PI
Probing the Cardiac PGC-1 Regulatory Cascade$477,500
R01 · FY2011 · HL · contact PI
A Genomic/Metabolomic Strategy to Characterize Cardiac Mitochondrial Dysfunction$780,976
R01 · FY2010 · HL · contact PI
Probing the adipocyte-myocyte axis: An Interdisciplinary Approach$573,000
R24 · FY2010 · DK · contact PI
Probing the Cardiac PGC-1 Regulatory Cascade$477,500
R01 · FY2010 · HL · contact PI
SCCOR in Cardiac Dysfunction and Disease$2,669,518
P50 · FY2009 · HL · contact PI
Molecular Control of Mitochondrial Fatty Acid Oxidation$549,381
R01 · FY2009 · DK · contact PI
Probing the Cardiac PGC-1 Regulatory Cascade$463,653
R01 · FY2009 · HL · contact PI
ALTERED PPARx SIGNALING IN THE ISCHEMIC DIABETIC HEART$444,919
P50 · FY2009 · HL · contact PI
SCCOR in Cardiac Dysfunction and Disease$2,521,768
P50 · FY2008 · HL · contact PI
ALTERED PPARx SIGNALING IN THE ISCHEMIC DIABETIC HEART$576,352
P50 · FY2008 · HL · contact PI
Molecular Control of Mitochondrial Fatty Acid Oxidation$548,548
R01 · FY2008 · DK · contact PI
Probing the Cardiac PGC-1 Regulatory Cascade$463,653
R01 · FY2008 · HL · contact PI
SCCOR in Cardiac Dysfunction and Disease$2,624,620
P50 · FY2007 · HL · contact PI
ALTERED PPARx SIGNALING IN THE ISCHEMIC DIABETIC HEART$562,112
P50 · FY2007 · HL · contact PI
Molecular Control of Mitochondrial Fatty Acid Oxidation$439,577
R01 · FY2007 · DK · contact PI
Probing the Cardiac PGC-1 Regulatory Cascade$371,408
R01 · FY2007 · HL · contact PI
SCCOR in Cardiac Dysfunction and Disease$2,765,109
P50 · FY2006 · HL · contact PI
Interdisciplinary Studies of the Diabetic Heart (RMI)$561,274
P20 · FY2006 · RR · contact PI
ALTERED PPARx SIGNALING IN THE ISCHEMIC DIABETIC HEART$546,396
P50 · FY2006 · HL · contact PI
Molecular Control of Mitochondrial Fatty Acid Oxidation$436,527
R01 · FY2006 · DK · contact PI
Probing the Cardiac PGC-1 Regulatory Cascade$382,500
R01 · FY2006 · HL · contact PI
Myocardial PPAR alpha in diabetic cardiomyopathy$378,303
P01 · FY2006 · HL · contact PI
PLANNING INTERDISCIPLINARY STUDIES OF DIABETIC HEART: TRANSLATIONAL & CLINICAL$112,255
P20 · FY2006 · RR · contact PI
PLANNING INTERDISCIPLINARY STUDIES OF DIABETIC HEART: PILOT RESEARCH PROJECTS$112,255
P20 · FY2006 · RR · contact PI
PLANNING INTERDISCIPLINARY STUDIES OF DIABETIC HEART: TECNOLOGY PLATFORM DVMT$112,255
P20 · FY2006 · RR · contact PI
PLANNING INTERDISCIPLINARY STUDIES OF DIABETIC HEART: FUNDAMENTAL DISCOVERY$112,255
P20 · FY2006 · RR · contact PI
PLANNING INTERDISCIPLINARY STUDY: DIABETIC HEART: COMPREHENSION PROPOSAL FOR IRC$112,254
P20 · FY2006 · RR · contact PI
HEPATIC FLUXES IN PGC-1 ALPHA KO MICE$11,740
P41 · FY2006 · RR · contact PI
SCCOR in Cardiac Dysfunction and Disease$2,785,749
P50 · FY2005 · HL
Interdisciplinary Studies of the Diabetic Heart (RMI)$587,088
P20 · FY2005 · RR
ALTERED PPARx SIGNALING IN THE ISCHEMIC DIABETIC HEART$521,203
P50 · FY2005 · HL
Molecular Control of Mitochondrial Fatty Acid Oxidation$434,358
R01 · FY2005 · DK
Myocardial PPAR alpha in diabetic cardiomyopathy$368,938
P01 · FY2005 · HL
Regulation of fatty acid oxidation during cardiac growth$306,000
R01 · FY2005 · HL
PLANNING INTERDISCIPLINARY STUDIES OF DIABETIC HEART: PILOT RESEARCH PROJECTS$117,418
P20 · FY2005 · RR
PLANNING INTERDISCIPLINARY STUDIES OF DIABETIC HEART: TRANSLATIONAL &CLINICAL$117,418
P20 · FY2005 · RR
PLANNING INTERDISCIPLINARY STUDIES OF DIABETIC HEART: TECNOLOGY PLATFORM DVMT$117,418
P20 · FY2005 · RR
PLANNING INTERDISCIPLINARY STUDIES OF DIABETIC HEART: FUNDAMENTAL DISCOVERY$117,418
P20 · FY2005 · RR
PLANNING INTERDISCIPLINARY STUDY: DIABETIC HEART: COMPREHENSION PROPOSAL FOR IRC$117,416
P20 · FY2005 · RR
Interdisciplinary Studies:The Diabetic Heart (RMI)$598,888
P20 · FY2004 · RR
Regulation of fatty acid oxidation during cardiac growth$306,000
R01 · FY2004 · HL
MOLECULAR CONTROL OF MITOCHONDRIAL FATTY ACID OXIDATION$269,500
R01 · FY2004 · DK
PLANNING INTERDISCIPLINARY STUDIES OF DIABETIC HEART: COMPREHENSION PROPOSAL FOR$119,778
P20 · FY2004 · RR
PLANNING INTERDISCIPLINARY STUDIES OF DIABETIC HEART: PILOT INTERDISCIPLINARY RE$119,778
P20 · FY2004 · RR
PLANNING INTERDISCIPLINARY STUDIES OF DIABETIC HEART: TRANSLATIONAL &CLINICAL I$119,778
P20 · FY2004 · RR
PLANNING INTERDISCIPLINARY STUDIES OF DIABETIC HEART: TECNOLOGY PLATFORM DEVELOP$119,778
P20 · FY2004 · RR
PLANNING INTERDISCIPLINARY STUDIES OF DIABETIC HEART: FUNDAMENTAL DISCOVERY$119,776
P20 · FY2004 · RR
1) Hypopituitarism after Moderate and Severe Head Injury and 2) Acute Seconda...$33,290
M01 · FY2004 · RR
Hypopituitarism Following Traumatic Brain Injury or Aneurysmal Subarachnoid H...$273
M01 · FY2004 · RR
MOLECULAR DETERMINANTS OF PEDIATRIC HEART DISEASE$1,785,336
P50 · FY2003 · HL
Regulation of fatty acid oxidation during cardiac growth$306,000
R01 · FY2003 · HL
MOLECULAR CONTROL OF MITOCHONDRIAL FATTY ACID OXIDATION$269,500
R01 · FY2003 · DK
MOLECULAR DETERMINANTS OF PEDIATRIC HEART DISEASE$1,803,815
P50 · FY2002 · HL
Myocardial PPAR alpha in diabetic cardiomyopathy$341,548
P01 · FY2002 · HL
Regulation of fatty acid oxidation during cardiac growth$306,500
R01 · FY2002 · HL
MOLECULAR CONTROL OF MITOCHONDRIAL FATTY ACID OXIDATION$269,500
R01 · FY2002 · DK
CORE--MOUSE CARDIOVASCULAR PHYSIOLOGY$0
P50 · FY2002 · HL
MOUSE MODELS OF ALTERED MYOCARDIAL FATTY ACID IMPORT AND UTILIZATION$0
P50 · FY2002 · HL
MOLECULAR DETERMINANTS OF PEDIATRIC HEART DISEASE$1,731,374
P50 · FY2001 · HL
MOLECULAR CONTROL OF MITOCHONDRIAL FATTY ACID OXIDATION$269,865
R01 · FY2001 · DK
REGULATION OF FATTY ACID OXIDATION DURING CARDIAC GROWTH$266,687
R01 · FY2001 · HL
CORE--MOUSE CARDIOVASCULAR PHYSIOLOGY$0
P50 · FY2001 · HL
MOUSE MODELS OF ALTERED MYOCARDIAL FATTY ACID IMPORT AND UTILIZATION$0
P50 · FY2001 · HL
REGULATION OF FATTY ACID OXIDATION DURING CARDIAC GROWTH$237,805
R01 · FY2000 · HL
CORE--MOUSE CARDIOVASCULAR PHYSIOLOGY$188,328
P50 · FY2000 · HL
MOUSE MODELS OF ALTERED MYOCARDIAL FATTY ACID IMPORT AND UTILIZATION$188,328
P50 · FY2000 · HL